Cargando…

Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

(1) Background: Alcohol Use Disorder (AUD) is associated with functional disruption of several brain structures that may trigger cognitive dysfunction. One of the mechanisms of alcohol-associated cognitive impairment has been proposed to arise from its direct impact on the immune system, which culmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Requena-Ocaña, Nerea, Flores-Lopez, María, Papaseit, Esther, García-Marchena, Nuria, Ruiz, Juan Jesús, Ortega-Pinazo, Jesús, Serrano, Antonia, Pavón-Morón, Francisco Javier, Farré, Magí, Suarez, Juan, Rodríguez de Fonseca, Fernando, Araos, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138236/ https://www.ncbi.nlm.nih.gov/pubmed/35625687 http://dx.doi.org/10.3390/biomedicines10050947

Ejemplares similares

Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

Influence of gender and education on cocaine users in an outpatient cohort in Spain
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019)

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
por: Flores-López, María, et al.
Publicado: (2022)

Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
por: Flores-López, María, et al.
Publicado: (2023)

Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
por: García-Marchena, Nuria, et al.
Publicado: (2022)

Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
por: García-Marchena, Nuria, et al.
Publicado: (2020)

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
por: Flores-López, María, et al.
Publicado: (2021)

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
por: Galván, Sandra Torres, et al.
Publicado: (2021)

Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
por: Araos, Pedro, et al.
Publicado: (2019)

Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
por: García-Marchena, Nuria, et al.
Publicado: (2018)

Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018)

Sex Differences in Psychiatric Comorbidity and Plasma Biomarkers for Cocaine Addiction in Abstinent Cocaine-Addicted Subjects in Outpatient Settings
por: Pedraz, María, et al.
Publicado: (2015)

Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation
por: Sanchez-Marin, Laura, et al.
Publicado: (2017)

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)

UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers
por: Pellegrini, Manuela, et al.
Publicado: (2020)

Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy
por: Romero-Sanchiz, Pablo, et al.
Publicado: (2020)

Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity
por: Pedraz, María, et al.
Publicado: (2015)

Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ(9)-THC and Ethanol Binge Drinking During Adolescence
por: Silva-Peña, Daniel, et al.
Publicado: (2019)

Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
por: Mas, Marta, et al.
Publicado: (2022)

Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis
por: Maza-Quiroga, Rosa, et al.
Publicado: (2017)

Repeated Restraint Stress and Binge Alcohol during Adolescence Induce Long-Term Effects on Anxiety-like Behavior and the Expression of the Endocannabinoid System in Male Rats
por: Sánchez-Marín, Laura, et al.
Publicado: (2022)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
por: Orio, Laura, et al.
Publicado: (2019)

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers
por: Martínez-Riera, Roser, et al.
Publicado: (2019)

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans
por: Papaseit, Esther, et al.
Publicado: (2021)

Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
por: Hladun, Olga, et al.
Publicado: (2021)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
por: Sanvisens, Arantza, et al.
Publicado: (2021)

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2018)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
por: Fonseca, Francina, et al.
Publicado: (2021)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfffidk5894upmldf63j6p92bj